Antonia N. Policheni
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer-related gene regulation, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Immunotherapy and Immune Responses
Most-Cited Works
- → The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments(2012)327 cited
- → Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer(2017)308 cited
- → Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3+ regulatory T cells(2013)233 cited
- → Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment(2018)217 cited
- → DEC-205 is a cell surface receptor for CpG oligonucleotides(2012)170 cited
- → A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer(2019)144 cited
- → Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer(2020)97 cited
- → Linear ubiquitin chain assembly complex coordinates late thymic T-cell differentiation and regulatory T-cell homeostasis(2016)62 cited
- → AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers(2024)56 cited
- → PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia(2019)50 cited